生命科学资讯

New CagriSema data show improvement over semaglutide

GSK returns rights to Wave's RNA editing program for AATD

Spring Health acquires Alma, expanding insurance reach in virtual mental health

Kyowa Kirin reveals side effect in trial; GSK was lone bidder for RAPT

FDA rejects Aquestive's allergy drug over packaging issues

FDA opens submissions for PreCheck program to speed up US factory builds

SanegeneBio licenses RNAi candidate to Genentech for $200M upfront

Pharming’s immunodeficiency drug gets CRL for use in younger patients

European law changes mean drugmakers may have to grapple with generic competition sooner

Big Pharma earnings kick off; Third-round IRA drugs selected; Hengrui’s trailblazing moment; and more

FDA says it explained issues early on for Corcept's rejected Cushing's syndrome drug

Bitterroot reverts to preclinical biotech in CD47 as CEO leaves

CHMP opposes Lilly’s Mounjaro in heart failure, backs Novo’s Kayshild

Ultragenyx resubmits gene therapy for rare neuro disease to FDA

Quince's steroid therapy for rare disease fails, shares tank

Janux hires CMO after T cell engager deal with Bristol Myers; A batch of appointments at Lexeo

Reed Jobs' cancer biotech investment firm Yosemite eyes $350M fund

AstraZeneca pays $1.2B for CSPC's long-acting obesity drugs

Takeda 'anticipated' Medicare negotiations for top seller Entyvio

Takeda is ‘not in favor’ of Trump’s MFN deals, CEO-designate says